ibandronic acid sodium monohydrate

It is prescribed to adults with breast cancer that has spread to the bones (bone metastases) to help prevent fractures and other bone problems that might require surgery or radiotherapy. It can also be used to treat high calcium levels in the blood caused by the tumor.

Form: tablets, film-coated

ATC: M05BA06

Manufacturer: ATNAHS PHARMA NETHERLANDS BV

It is prescribed to treat postmenopausal osteoporosis in women at high risk of fractures. The drug helps to block bone loss and increase bone mass, reducing the possibility of spinal fractures.

Form: tablets, film-coated

ATC: M05BA06

Manufacturer: ATNAHS PHARMA NETHERLANDS BV

This medicine is prescribed for two different purposes depending on the dosage: for adults with breast cancer that has spread to the bones (bone metastases), to help prevent fractures and other bone problems; or to treat postmenopausal osteoporosis in women at high risk of fractures.

Form: tablets, film-coated

ATC: M05BA06

Manufacturer: TEVA B.V.

It is prescribed for the treatment of postmenopausal osteoporosis in women who have developed an increased risk of bone fractures. The drug helps to block the loss of bone tissue and increase bone mass, reducing the probability of spinal fractures.

Form: tablets, film-coated

ATC: M05BA06

Manufacturer: AUROBINDO PHARMA (ITALIA) S.R.L.

It is prescribed to treat postmenopausal osteoporosis in women at higher risk of fractures. The drug helps to reverse bone loss and can decrease the possibility of spinal fractures.

Form: tablets, film-coated

ATC: M05BA06

Manufacturer: MYLAN S.P.A.

It is prescribed to treat postmenopausal osteoporosis in women at high risk of fractures. It can help reduce bone loss and decrease the possibility of spinal fractures.

Form: tablets, film-coated

ATC: M05BA06

Manufacturer: TOWA PHARMACEUTICAL S.P.A.